Policies · 4 sources combined
Pediatric, emergency essential drugs
Designated as exit-prevention medicines
In short
Triazolam Injection (seizure treatment for children) will be designated as an exit-prevention medicine starting November 1, 2026.
Supply could have been cut off due to only one domestic production facility, but the government protected it by covering production costs.
Drug prices for 14 items including chemotherapy drugs Holoxan and Endoxan will also be adjusted to reflect reality.
Key facts
| When | Triazolam Injection will be designated as an exit-prevention medicine starting November 1, 2026. |
|---|---|
| Who | The Ministry of Health and Welfare has promoted this in cooperation with the Ministry of Food and Drug Safety. |
| What | Essential medicines for pediatric seizures and brain epilepsy sedation, plus drug prices for 14 items have been improved. |
| How | Production will be stabilized by covering costs, and 20 billion won in annual government spending will be saved. |
What it means for me
Essential medicine supply at medical facilities will become stable, but general readers will experience little immediate change.
